Fidelity National Financial, Inc. (FNF)
Live price chart, market sentiment, and community perspectives for Fidelity National Financial, Inc. (NYSE: FNF).
Live price chart, market sentiment, and community perspectives for Fidelity National Financial, Inc. (NYSE: FNF).
On our desk, the 4.5% post-earnings selloff down to $50.18 looked completely detached from reality. FNF posted a clear beat-and-raise quarter with Q2 revenue hitting $4.05 billion versus the $3.83 billion consensus. The market is myopically trading rate sensitivity and macro fear rather than the impressive 17.8% adjusted pre-tax title margins. We view this pullback as a textbook sentiment mispricing.
Looking closely at the capital allocation strategy, management is walking the walk. Alongside a quarterly cash dividend hike to $0.52 per share, FNF completed $390.19 million in share repurchases under its August 2024 program. When you combine this level of cash return with an 8.4x forward P/E on $15.4 billion TTM revenue, the risk-reward skew heading into the back half of 2026 looks heavily tilted toward the bulls.
During our prep for the commercial real estate sleeve, we zeroed in on CEO Mike Nolan's Q2 commentary regarding commercial revenue trending toward historic highs. The 32% jump in commercial title revenue to $440 million—backed by broad-based recovery in industrial, data center, and multifamily asset classes—proves that FNF's diversification is functioning exactly as modeled despite subdued residential volumes.
Hedging our long exposure with Q4 out-of-the-money put spreads given the unpredictable trajectory of the 10-year Treasury yield. The fundamental business is firing on all cylinders—demonstrated by adjusted net earnings rising to $370 million and outperformance in sequential daily opened orders relative to peers—but macro rate volatility remains the primary exogenous threat to near-term multiple re-rating.
Watching the 50-day MA and analyst QandA dynamics, Bose George of KBW rightly pressed management on the operating margin compression down to 8.3% from 10.5% a year ago. While operational leverage and cost discipline helped secure record FandG AUM of $74.7 billion, investors need to monitor whether persistent inflationary pressures will cap multiple expansion despite strong top-line beats.
Explore plasma cleansing, somatic organ swaps, and BCI.